| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d289e9bc13497c273bc981cdbd3668dd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate |
2016-03-14^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-07-31^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f99755cd02ef2a505082d49ec4d6a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6170a22ca151524468a5e500b83cb94a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d86d3273e47c3fa12ca7423cc9e6f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_004c7efc75be2b599098012ce61c4490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e761808dd3251363ee54b27a6931d483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f24332ac75e08b658f5d1224fdf950 |
| publicationDate |
2018-07-31^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10034833-B2 |
| titleOfInvention |
Sublingual and buccal film compositions |
| abstract |
The present invention relates to products and methods for treatment of various symptoms in a patient, including treatment of pain suffered by a patient. The invention more particularly relates to self-supporting dosage forms which provide an active agent while providing sufficient buccal adhesion of the dosage form. Further, the present invention provides a dosage form which is useful in reducing the likelihood of diversion abuse of the active agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021244655-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10821074-B2 |
| priorityDate |
2009-08-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |